ArticleThoracic cancer2022

Genetic variants in LKB1/AMPK/mTOR pathway are associated with clinical outcomes of chemotherapy in non-small cell lung cancer.

Sun Ha Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.